Market Place
Sourcing Support
Ethiopian Team Visits Telangana for Drug Regulation Study
28 Nov 2025 //
PHARMABIZ
Torrent Pharma Fined Rs 41 Crore Over Alleged Wrong GST Refund
28 Nov 2025 //
ECONOMICTIMES
FDA Grants VAI Status to Biocon`s Bengaluru Facility
27 Nov 2025 //
ECONOMICTIMES
CDSCO Bans High-Risk Solvents in Pediatric Oral Drugs
27 Nov 2025 //
BUSINESS STD
Glenmark Pharma Gets VAI From FDA For Monroe Facility
27 Nov 2025 //
INDPHARMAPOST
CDSCO Panel Calls For Consistent Drug Standard Enforcement
27 Nov 2025 //
BUSINESS STD
Telangana DCA Enforces CDSCO Mandate For Drug Safety Reporting
26 Nov 2025 //
PHARMABIZ
Sanofi Caught Up In Tax Fraud Probe Involving Several Companies
26 Nov 2025 //
FIERCE PHARMA
Haryana FDA Hosts Summit on Spurious Drugs, NDPS Fight
25 Nov 2025 //
PHARMABIZ
Abbott Urgently Corrects Freestyle Libre 3 Sensors Over Safety
25 Nov 2025 //
INDPHARMAPOST
Commenters Advocate For Clearer Safety Label Guidance
24 Nov 2025 //
RAPS
Lupin Gets 7 Observations From USFDA For Goa Facility
24 Nov 2025 //
INDPHARMAPOST
CDSCO Reports Highest Number Of NSQs In 2025 In October
24 Nov 2025 //
PHARMABIZ
Shilpa Medicare Gets 8 Observations From FDA For Jadcherla Unit 4
24 Nov 2025 //
INDPHARMAPOST
Abbott To Replace CGMs After Incorrect Readings, Death Reports
24 Nov 2025 //
FIERCE BIOTECH
Solara`s Mangalore Facility Clears FDA Inspection With VAI Status
23 Nov 2025 //
INDPHARMAPOST
CDSCO Identifies 211 Drug Samples As NSQs, 5 As Spurious
22 Nov 2025 //
PHARMABIZ
NATCO API unit gets 7 observations from FDA Read more
22 Nov 2025 //
ET PHARMA
AIOCD Asks Traders To Strictly Comply With The Ban On 35 Fdcs
21 Nov 2025 //
PHARMABIZ
NABL Sets Terms For Labs To Obtain And Keep Accreditation
21 Nov 2025 //
PHARMABIZ
Piramal Pharma Solutions` UK Site Secures Renewed MHRA GMP
21 Nov 2025 //
INDPHARMAPOST
Texas Sues Sanofi, BMS Over `Deceptive` Plavix Marketing
21 Nov 2025 //
FIERCE PHARMA
Takeda`s Adzynma draws FDA scrutiny after paediatric death
21 Nov 2025 //
FDA
Pfizer, Tris Settle ADHD Drug Claims With $41.5M In Texas
20 Nov 2025 //
FIERCE PHARMA
Regulator Tightens Rules on High-Risk Solvents Post Syrup Deaths
19 Nov 2025 //
ECONOMICTIMES
KSMSCL Strengthens Drug Procurement With Quarantine Measures
18 Nov 2025 //
PHARMABIZ
OTC Morning-After Pills Sold in Varying Doses with Warnings
18 Nov 2025 //
ECONOMICTIMES
Astrazeneca Lands OPDP Untitled Letter Over Farxiga TV Ad
17 Nov 2025 //
RAPS
AIOCD & RDCA Support Regulatory Crackdown On MTP & Narcotic Drug
17 Nov 2025 //
PHARMABIZ
Medico Remedies Receives GMP Certificate From SMDC, In Ukraine
16 Nov 2025 //
INDPHARMAPOST
Aurobindo Pharma Receives 9 Observations From USFDA For Eugia
15 Nov 2025 //
INDPHARMAPOST
Regulator Tightens Quality Checks, Threatening Small Pharma Firms
13 Nov 2025 //
ECONOMICTIMES
Omnicell Secures URAC Certification For Health System Pharmacies
13 Nov 2025 //
BUSINESSWIRE
FDA Warns Companies For GMP And Unapproved Drug Violations
13 Nov 2025 //
RAPS
HEMP Crackdown, Court Rulings Reinforce MMJ’s Pharma Vision
12 Nov 2025 //
PHARMIWEB
Fresenius, Sun, Teva & Others Launched Drug Recalls This Fall
12 Nov 2025 //
FIERCE PHARMA
Byheart Broadens Voluntary Recall While Investigation Continues
11 Nov 2025 //
BUSINESSWIRE
Marksans Pharma`s Goa Unit Clears FDA Inspection
10 Nov 2025 //
INDPHARMAPOST
CDSCO Orders Inspections Of MSME Pharma Units As Schedule M
09 Nov 2025 //
BUSINESS STD
Drug Regulator For Strict Compliance With New Schedule M
08 Nov 2025 //
ECONOMICTIMES
Byheart Voluntarily Recalls Two Infant Formula Batches Amid FDA
08 Nov 2025 //
BUSINESSWIRE
Vivazen Supports Kentucky`s Consumer Protection Against 7-OH
06 Nov 2025 //
BUSINESSWIRE
Fresenius Kabi Recalls 3 Lots Of Famotidine Injection
06 Nov 2025 //
BUSINESSWIRE
FDA Warns Companies On Illegal Marketing Of Botox & Related
05 Nov 2025 //
GLOBENEWSWIRE
Haryana DCA Seals 16 Sirsa Medical Shops For Illegal Drug Sales
05 Nov 2025 //
PHARMABIZ
Odisha Ex-Dc Proposes Landmark Guidelines For Spurious Drug
03 Nov 2025 //
PHARMABIZ
FDA Issues Draft Guidance On QMSR Information For Premarket
03 Nov 2025 //
RAPS
FDA Warns Four Firms For Unapproved Children`s Fluoride Drugs
31 Oct 2025 //
REUTERS
FDA Warns Philips for Manufacturing and Quality System Issues
31 Oct 2025 //
INDPHARMAPOST
Centre Drafts Rules To Ban Drugmakers For Providing False Inform
29 Oct 2025 //
BUSINESS STD
Drug Company Forging Data for, Mislabelled Brand to Be Barred
29 Oct 2025 //
ECONOMICTIMES
IPC to Host TB Elimination Stakeholder Meet on October 30
28 Oct 2025 //
PHARMABIZ
Nextgen Bio Passes Initial FDA Audit With No Observations
28 Oct 2025 //
GLOBENEWSWIRE
SK Pharmteco Earn Top My Green Lab Certifications In Europe, Asia
28 Oct 2025 //
BUSINESSWIRE
Pharmas Hope FDA PreCheck Can Help Avoid Facility Drug Rejections
28 Oct 2025 //
BIOSPACE
Haryana DC Introduces Digital System To Monitor High-Risk Solvent
28 Oct 2025 //
PHARMABIZ
FDA Official Issues Warning About Looming Biosimilar Void
28 Oct 2025 //
RAPS
FDA Rejects Eylea HD For Ongoing Manufacturing Issues
28 Oct 2025 //
FIERCE PHARMA
PvPI Detects 16 India-Specific Signals, 183 Drug Safety Alerts
27 Oct 2025 //
PHARMABIZ
CDSCO Releases 1,700 Standards For Medical Equipment Compliance
27 Oct 2025 //
PHARMABIZ
